| Cardiovascular disease and cancer: evidence for shared disease pathways and pharmacologic prevention F Masoudkabir, N Sarrafzadegan, C Gotay, A Ignaszewski, AD Krahn, ... Atherosclerosis 263, 343-351, 2017 | 147 | 2017 |
| Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting SE Kassaian, H Goodarzynejad, MA Boroumand, M Salarifar, ... Cardiovascular diabetology 11, 1-10, 2012 | 110 | 2012 |
| N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a … M Amini, M Salarifar, A Amirbaigloo, F Masoudkabir, F Esfahani Trials 10, 1-6, 2009 | 107 | 2009 |
| Effects of opium consumption on cardiometabolic diseases F Masoudkabir, N Sarrafzadegan, MJ Eisenberg Nature Reviews Cardiology 10 (12), 733-740, 2013 | 70 | 2013 |
| Hemodialysis adequacy and treatment in Iranian patients a national multicenter study MR RASOULI, E POURBAKHTYARAN, M AMINI, M AGHIGHI, ... IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD) 5 (2), 103-109, 2011 | 69 | 2011 |
| Opium consumption and coronary atherosclerosis in diabetic patients: a propensity score-matched study SK Hosseini, F Masoudkabir, A Vasheghani-Farahani, S Alipour-Parsa, ... Planta medica 77 (17), 1870-1875, 2011 | 51 | 2011 |
| Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy N Rezvan, MJ Hosseinzadeh-Attar, F Masoudkabir, A Moini, L Janani, ... Archives of gynecology and obstetrics 285, 1257-1262, 2012 | 48 | 2012 |
| Effect of diet-induced weight loss on inflammatory cytokines in obese women N Tajik, SA Keshavarz, F Masoudkabir, M Djalali, ... Journal of endocrinological investigation 36, 211-215, 2013 | 47 | 2013 |
| Visceral obesity and its shared role in cancer and cardiovascular disease: A scoping review of the pathophysiology and pharmacological treatments E Aparecida Silveira, G Vaseghi, AS de Carvalho Santos, N Kliemann, ... International journal of molecular sciences 21 (23), 9042, 2020 | 45 | 2020 |
| Clinical characteristics, management and 1-year outcomes of patients with acute coronary syndrome in Iran: the Iranian Project for Assessment of Coronary Events 2 (IPACE2) SE Kassaian, F Masoudkabir, H Sezavar, M Mohammadi, ... BMJ open 5 (12), e007786, 2015 | 42 | 2015 |
| Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects A Golpaie, N Tajik, F Masoudkabir, Z Karbaschian, M Talebpour, ... European Cytokine Network 22 (4), 181-186, 2011 | 42 | 2011 |
| The association of liver transaminase activity with presence and severity of premature coronary artery disease F Masoudkabir, S Karbalai, A Vasheghani-Farahani, LL Aliabadi, ... Angiology 62 (8), 614-619, 2011 | 40 | 2011 |
| PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region N Sarrafzadegan, R Hassannejad, HR Marateb, M Talaei, M Sadeghi, ... PLoS One 12 (12), e0189389, 2017 | 31 | 2017 |
| Efficacy and safety of same‐day discharge after atrial fibrillation ablation: A systematic review and meta‐analysis S Rashedi, H Tavolinejad, S Kazemian, M Mardani, M Masoudi, ... Clinical Cardiology 45 (2), 162-172, 2022 | 25 | 2022 |
| Synergistic effect of hypertension with diabetes mellitus and gender on severity of coronary atherosclerosis: Findings from Tehran Heart Center registry F Masoudkabir, H Poorhosseini, A Vasheghani-Farahani, E Hakki, ... ARYA atherosclerosis 11 (6), 317, 2015 | 21 | 2015 |
| Prevalence, awareness, treatment, and control of type 2 diabetes mellitus among the adult residents of tehran: Tehran Cohort Study A Oraii, A Shafiee, A Jalali, F Alaeddini, S Saadat, F Masoudkabir, ... BMC endocrine disorders 22 (1), 248, 2022 | 20 | 2022 |
| Sagittal abdominal diameter to triceps skinfold thickness ratio: a novel anthropometric index to predict premature coronary atherosclerosis A Vasheghani-Farahani, K Majidzadeh-A, F Masoudkabir, S Karbalai, ... Atherosclerosis 227 (2), 329-333, 2013 | 20 | 2013 |
| Opium and cardiovascular health: a devil or an angel? P Roayaei, A Aminorroaya, A Vasheghani-Farahani, A Oraii, S Sadeghian, ... Indian Heart Journal 72 (6), 482-490, 2020 | 18 | 2020 |
| Portal and systemic levels of visfatin in morbidly obese subjects undergoing bariatric surgery Z Karbaschian, MJ Hosseinzadeh-Attar, L Giahi, A Golpaie, ... Endocrine 44, 114-118, 2013 | 16 | 2013 |
| Comparison of cardiovascular risk factors and biochemical profile in patients with cardiac syndrome X and obstructive coronary artery disease: A propensity score-matched study A Vasheghani-Farahani, N Nouri, S Seifirad, MS Fathollahi, E Hakki, ... ARYA atherosclerosis 9 (5), 269, 2013 | 14 | 2013 |
ali Vasheghani-FarahaniProfessor of Medicine, Tehran University of Medical SciencesVerified email at tums.ac.ir
